Literature DB >> 15655111

Distinct functions of junD in cardiac hypertrophy and heart failure.

Romeo Ricci1, Urs Eriksson, Gavin Y Oudit, Robert Eferl, Alexander Akhmedov, Izabela Sumara, Grzegorz Sumara, Zamaneh Kassiri, Jean-Pierre David, Latifa Bakiri, Bernd Sasse, Maria-Helena Idarraga, Martina Rath, David Kurz, Hans-Christian Theussl, Jean-Claude Perriard, Peter Backx, Josef M Penninger, Erwin F Wagner.   

Abstract

Cardiac hypertrophic stimuli induce both adaptive and maladaptive growth response pathways in heart. Here we show that mice lacking junD develop less adaptive hypertrophy in heart after mechanical pressure overload, while cardiomyocyte-specific expression of junD in mice results in spontaneous ventricular dilation and decreased contractility. In contrast, fra-1 conditional knock-out mice have a normal hypertrophic response, whereas hearts from fra-1 transgenic mice decompensate prematurely. Moreover, fra-1 transgenic mice simultaneously lacking junD reveal a spontaneous dilated cardiomyopathy associated with increased cardiomyocyte apoptosis and a primary mitochondrial defect. These data suggest that junD promotes both adaptive-protective and maladaptive hypertrophy in heart, depending on its expression levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655111      PMCID: PMC545879          DOI: 10.1101/gad.327005

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  32 in total

Review 1.  Signaling pathways for cardiac hypertrophy and failure.

Authors:  J J Hunter; K R Chien
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Sensing heart stress.

Authors:  Liza Barki-Harrington; Howard A Rockman
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

Review 3.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

4.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.

Authors:  N Wettschureck; H Rütten; A Zywietz; D Gehring; T M Wilkie; J Chen; K R Chien; S Offermanns
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

5.  Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways.

Authors:  Michael A Crackower; Gavin Y Oudit; Ivona Kozieradzki; Renu Sarao; Hui Sun; Takehiko Sasaki; Emilio Hirsch; Akira Suzuki; Tetsuo Shioi; Junko Irie-Sasaki; Rajan Sah; Hai-Ying M Cheng; Vitalyi O Rybin; Giuseppe Lembo; Luigi Fratta; Antonio J Oliveira-dos-Santos; Jeffery L Benovic; C Ronald Kahn; Seigo Izumo; Susan F Steinberg; Matthias P Wymann; Peter H Backx; Josef M Penninger
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

6.  Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts.

Authors:  J E van Wamel; C Ruwhof; E J van der Valk-Kokshoorn; P I Schrier; A van der Laarse
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

7.  Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.

Authors:  Francisco J Naya; Brian L Black; Hai Wu; Rhonda Bassel-Duby; James A Richardson; Joseph A Hill; Eric N Olson
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

Review 8.  Genomic circuits and the integrative biology of cardiac diseases.

Authors:  K R Chien
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Composition and function of AP-1 transcription complexes during muscle cell differentiation.

Authors:  John J Andreucci; Diane Grant; David M Cox; Lyn K Tomc; Ron Prywes; David J Goldhamer; Natalie Rodrigues; Pierre-André Bédard; John C McDermott
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

10.  Melusin, a muscle-specific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload.

Authors:  Mara Brancaccio; Luigi Fratta; Antonella Notte; Emilio Hirsch; Roberta Poulet; Simona Guazzone; Marika De Acetis; Carmine Vecchione; Gennaro Marino; Fiorella Altruda; Lorenzo Silengo; Guido Tarone; Giuseppe Lembo
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

View more
  12 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration.

Authors:  Genzou Takemura; Hiromitsu Kanamori; Hideshi Okada; Nagisa Miyazaki; Takatomo Watanabe; Akiko Tsujimoto; Kazuko Goto; Rumi Maruyama; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 4.  Ageing, metabolism and cardiovascular disease.

Authors:  Sarah Costantino; Francesco Paneni; Francesco Cosentino
Journal:  J Physiol       Date:  2015-10-22       Impact factor: 5.182

Review 5.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

6.  Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.

Authors:  Manjunath Yariswamy; Tadashi Yoshida; Anthony J Valente; Hemanth Kumar Kandikattu; Siva S V P Sakamuri; Jalahalli M Siddesha; Sergiy Sukhanov; Zubaida Saifudeen; Lixin Ma; Ulrich Siebenlist; Jason D Gardner; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

Review 7.  The role of oxidative stress and inflammation in cardiovascular aging.

Authors:  Junzhen Wu; Shijin Xia; Bill Kalionis; Wenbin Wan; Tao Sun
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

8.  Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis.

Authors:  Liming Pan; Mengting Sheng; Zirui Huang; Zhilin Zhu; Chunli Xu; Lin Teng; Ling He; Chen Gu; Cai Yi; Junming Li
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

9.  The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart.

Authors:  Renata Windak; Julius Müller; Allison Felley; Alexander Akhmedov; Erwin F Wagner; Thierry Pedrazzini; Grzegorz Sumara; Romeo Ricci
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Small molecule inhibitors targeting activator protein 1 (AP-1).

Authors:  Na Ye; Ye Ding; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2014-05-27       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.